Year: 2020

Jack Syage Selected to Orange County Business Journal OC 500 Directory of Influence

Read More

ImmunogenX Publishes in Celiac Disease Journal

Read More

ImmunogenX and Mayo Clinic CeliacShield Trial for Latiglutenase Passes Safety and Efficacy Midterm Assessment

Read More

Enrollment Begins for Latiglutenase (IMGX003) Phase 2b Trial for Treatment of Celiac Disease

Read More

New Phase 2 Clinical Trial for Symptomatic Celiac Disease Patients Launches

Read More

Jack Syage Featured Speaker at 2020 Celiac Disease Foundation Summit

Read More

ImmunogenX Featured Again in the Orange County Business Journal

Read More

Potential Drug for Celiac Disease Improves Symptoms and Quality of Life in Some Patients

Read More
Contact Us
ZymagenX
1600 Dove Street, Suite 330, Newport Beach, CA, 92660
Copyright © 2025 ZymagenX, Inc.